title: Itraconazole as an alternative for ritonavir liquid formulation when combined with saquinavir.
authors.forename: C H
authors.initials: CH
authors.lastname: Koks
authors.forename: R P
authors.initials: RP
authors.lastname: van Heeswijk
authors.forename: A I
authors.initials: AI
authors.lastname: Veldkamp
authors.forename: P L
authors.initials: PL
authors.lastname: Meenhorst
authors.forename: J W
authors.initials: JW
authors.lastname: Mulder
authors.forename: J T
authors.initials: JT
authors.lastname: van der Meer
authors.forename: J H
authors.initials: JH
authors.lastname: Beijnen
authors.forename: R M
authors.initials: RM
authors.lastname: Hoetelmans
mesh_terms: D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D015497:HIV-1; D006801:Humans; D017964:Itraconazole / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D019438:Ritonavir / Q000627:therapeutic use*; D019258:Saquinavir / Q000493:pharmacokinetics*
chemical_list: D017320:HIV Protease Inhibitors; D017964:Itraconazole; D019258:Saquinavir; D019438:Ritonavir